Premium
Serum Immunoglobulin Concentrations in Diabetic Patients
Author(s) -
Ardawi MSM,
Nasrat H.A.N.,
Bahnassy A.A.
Publication year - 1994
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.1994.tb00290.x
Subject(s) - fructosamine , medicine , diabetes mellitus , endocrinology , pathogenesis , immunoglobulin a , antibody , population , type 2 diabetes , immunoglobulin g , immunology , environmental health
The relationship between glycated haemoglobin (an index of long‐term diabetic control), fructosamine (an index of intermediate‐term diabetic control), and serum IgA, IgG, and IgM was studied in 110 diabetic patients (41 Type 1 and 69 Type 2) and compared with 111 healthy non‐diabetic subjects. Significant increases in serum IgA (by 82.7%, p < 0.001) and IgG (by 35.2%, p < 0.001) concentrations were observed whereas the concentration of IgM was significantly decreased (by 46.7%, p < 0.001) in diabetic patients compared with non‐diabetic subjects. Using Spearman's rank correlations, IgA correlated with fructosamine ( r = 0.77, p < 0.001), HbA 1 ( r = 0.76, p < 0.001), and albumin ( r = −0.58, p < 0.001) for the entire population sample but only fructosamine ( r = 0.19, p < 0.05) and HbA 1 ( r = 0.28, p < 0.001) correlated with IgA in diabetic patients, respectively. It is concluded that abnormal levels of IgA, IgG, and IgM are very common in diabetic patients in whom serum IgA concentrations are influenced by the degree of glycaemic control. Whether changes in IgA and other immunoglobulins are implicated in the pathogenesis of diabetic complications (such as susceptibility to infection) deserve further study.